Indication for the prophylactic total gastrectomy in the hereditary diffuse gastric cancer in carriers of E-Cadherin mutation. Two observations

被引:0
|
作者
Godlewski, G. [1 ]
Chiesa, J. [4 ]
Pujol, P. [2 ]
Bourgaud, J. F. [3 ]
Pignodel, C.
Prudhomme, M. [1 ]
机构
[1] CHU, Hop Caremeau, Dept Chirurg Digestive, F-30029 Nimes, France
[2] CHU Montpellier, Hop Arnaud Villeneuve, Serv Genet Med, F-34295 Montpellier, France
[3] CHU, Serv Cytogenet, Nimes, France
[4] CHU, Lab Anatomie Pathol, F-30029 Nimes, France
来源
关键词
Gastric cancer; E; -Cadherin; CDH1; Hereditary diffuse gastric cancer;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim : The germ-line truncating mutation in the E-Cadherin, CDH1, is identified in 30% of hereditary diffuse gastric cancer (CGDH). The tumors are characterized by a high penetrance with an autosomal dominant pattern of inheritance, predominantly in young people. The endoscopic surveillance, by current methods, is largely ineffective because most tumors are growing up diffusely and quickly. We report the outcomes of 2 asymptomatic patients with the CDH1 mutation who have undergone prophylactic total gastrectomy (GTP). Patients and methods: Two brothers 22 and 33 years old, belonging to a family severely altered by CGD, underwent prophylactic total gastrectomy with Roux en Y reconstruction. Results: Pathologic examination of the stomach shows no evidence of in situ or invasive carcinoma despite multiple samples. There were no operative complications. A 5-5 kg weight loss and diarrhea stabilised in a 3 month period. There were no more complications in the long term. Discussion: Four points are discussed: 1/ The preoperative endoscopic screening for visualisation of carcinoma microfoci and of gastric ectopia in oesophagus. 2/ The interest of the chromoendoscopic surveillance unfortunately limited by size of tumoral foci never detectable if inferior to 4mm. 3/ The precision of the surgical procedure needing a complete removal of gastric mucosa that means GTP in every case. 4/ Regular screening for malignancies of other organs related to the CDH1 mutation (breast, colon-rectum, prostate). 5/ A proposition of therapeutic decisions for CGDH. Conclusion. The GTP indication is often difficult to promote for asymptomatic patients, but the operation avoids any risk of gastric cancer. Nevertheless the GTP cannot dispense patients of regular polyvisceral surveillance.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [21] Prophylactic total gastrectomy for hereditary diffuse gastric cancer: surgical and pathological results
    Pandalai, P. K.
    Patel, D.
    Chung, D. C.
    Lauwers, G. Y.
    Yoon, S. S.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S70 - S70
  • [22] Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature
    Mastoraki, Aikaterini
    Danias, Nikolaos
    Arkadopoulos, Nikolaos
    Sakorafas, George
    Vasiliou, Pantelis
    Smyrniotis, Vasilios
    SURGICAL ONCOLOGY-OXFORD, 2011, 20 (04): : E223 - E226
  • [23] A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer
    Ghaffari, S. R.
    Rafati, M.
    Sabokbar, T.
    Dastan, J.
    EJSO, 2010, 36 (06): : 559 - 562
  • [24] A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain
    Rodriguez-Sanjuan, J. C.
    Fontalba, A.
    Mayorga, M.
    Bordin, M. C.
    Hyland, S. J.
    Trugeda, S.
    Garcia, R. A.
    Gomez-Fleitas, M.
    Fernandez, F.
    Caldas, C.
    Fernandez-Luna, J. L.
    EJSO, 2006, 32 (10): : 1110 - 1113
  • [25] HEREDITARY DIFFUSE GASTRIC CANCER - SURVEILLANCE OR PROPHYLACTIC GASTRECTOMY
    Blair, Vanessa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 80 - 80
  • [26] Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome
    Newman, EA
    Mulholland, MW
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (04) : 612 - 617
  • [27] E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma
    Lynch, HT
    Grady, W
    Lynch, JF
    Tsuchiya, KD
    Wiesner, G
    Markowitz, SD
    CANCER GENETICS AND CYTOGENETICS, 2000, 122 (01) : 1 - 6
  • [28] Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome
    Teke, Martha E.
    Gamble, Lauren A.
    Samaranayake, Sarah G.
    Green, Benjamin L.
    Saif, Areeba
    Hernandez, Jonathan M.
    Davis, Jeremy L.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (13) : 7955 - 7957
  • [29] Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome
    Martha E. Teke
    Lauren A. Gamble
    Sarah G. Samaranayake
    Benjamin L. Green
    Areeba Saif
    Jonathan M. Hernandez
    Jeremy L. Davis
    Annals of Surgical Oncology, 2022, 29 : 7955 - 7957
  • [30] Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening
    Carneiro, F
    Huntsman, DG
    Smyrk, TC
    Owen, DA
    Seruca, R
    Pharoah, P
    Caldas, C
    Sobrinho-Simoes, M
    JOURNAL OF PATHOLOGY, 2004, 203 (02): : 681 - 687